Company / Current Liabilities per Share
Immunome Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.70
FY2025
5-year range
$0.60 / $1.80
FY2021-FY2025
Trend
-44.4%
vs FY2024
Sector context
#133 of 210
Health Care
What the data says
At $0.70, Immunome Inc.'s current liabilities per share ranks #78 of 210 in the Health Care sector. Improved from $1.80 to $0.70 over the past 2 years.
Based on SEC 10-K filings.
0.70 in FY2025 with a 5-year CAGR of -4.9%.
Improved from $1.80 to $0.70 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- -4.9%
- 10-Year CAGR
- -
Sector benchmark
#78 of 210 in Health CareTop 37% of 210This company $0.70 Sector average $15.78
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 44.4% year-over-year.
- Ranks #133 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.70 | -44.4% |
| FY2024 | $1.26 | -30.2% |
| FY2023 | $1.80 | +197.7% |
| FY2022 | $0.60 | -28.3% |
| FY2021 | $0.84 | -5.9% |
| FY2020 | $0.90 | -41.1% |
| FY2019 | $1.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026